Is hyponatremia a novel marker of inflammation in patients with COVID-19?

Journal Article Corrected proof Is hyponatremia a novel marker of inflammation in patients with COVID-19? Get access Juan Carlos Ayus, Juan Carlos Ayus Division of Nephrology, Hypertension, and Kidney Transplantation, University of California Irvine, Orange, CA, USA Correspondence to: Juan Carlos Ayus; E-mail: Carlosayus@yahoo.com Search for other works by this author on: Oxford Academic PubMed Google Scholar Kamyar Kalantar-Zadeh, Kamyar Kalantar-Zadeh Division of Nephrology, Hypertension, and Kidney Transplantation, University of California Irvine, Orange, CA, USADivision of Nephrology and Hypertension, Harbor-UCLA Medical Center, Torrance, CA, USA https://orcid.org/0000-0002-8666-0725 Search for other works by this author on: Oxford Academic PubMed Google Scholar Ekamol Tantisattamo, Ekamol Tantisattamo Division of Nephrology, Hypertension, and Kidney Transplantation, University of California Irvine, Orange, CA, USA https://orcid.org/0000-0003-0883-6892 Search for other works by this author on: Oxford Academic PubMed Google Scholar Connie M Rhee, Connie M Rhee Division of Nephrology, Hypertension, and Kidney Transplantation, University of California Irvine, Orange, CA, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Armando L Negri Armando L Negri Nephrology Section, Instituto de Investigaciones Metabólicas, Universidad del Salvador, Buenos Aires, Argentina Search for other works by this author on: Oxford Academic PubMed Google Scholar Nephrology Dialysis Transplantation, gfad111, https://doi.org/10.1093/ndt/gfad111 Published: 27 May 2023 Article history Received: 26 February 2023 Published: 27 May 2023 Corrected and typeset: 14 June 2023